Medical News
Latest News on Primary Aldosteronism
- CASZ1 found as possible monogenic cause of primary aldosteronism November 19, 2024Primary aldosteronism (PA), caused by bilateral adrenal hyperplasia or aldosteronomas, is the leading cause of endocrine hypertension, with an estimated prevalence of 10%-20% in patients in tertiary hospitals.bioworld.com
- Beyond pharmacotherapy: bilateral adrenal artery embolization as a potential game-changer for idiopathic hyperaldosteronism patients November 14, 2024Hypertension Research - Beyond pharmacotherapy: bilateral adrenal artery embolization as a potential game-changer for idiopathic hyperaldosteronism patientsHironobu Umakoshi
- Target organ damage in primary aldosteronism and captopril challenge test November 14, 2024Hypertension Research - Target organ damage in primary aldosteronism and captopril challenge testAkihiro Tojo
- Nonsteroidal MR antagonism in PA: clinical outcomes and unanswered questions November 14, 2024Hypertension Research - Nonsteroidal MR antagonism in PA: clinical outcomes and unanswered questionsDaigoro HirohamaShigeru Shibata
- Antihypertensive effects and changes in extracellular water content by mineralocorticoid receptor antagonists in patients with primary aldosteronism November 14, 2024Hypertension Research - Antihypertensive effects and changes in extracellular water content by mineralocorticoid receptor antagonists in patients with primary aldosteronismNature
- Autonomous cortisol secretion promotes vascular calcification in vivo and in vitro under hyperaldosteronism November 8, 2024Hypertension Research - Autonomous cortisol secretion promotes vascular calcification in vivo and in vitro under hyperaldosteronismNature
- Frontiers | Chronological outcomes of renal function after adrenalectomy in patients with primary aldosteronism across age groups November 7, 2024BackgroundPatients with primary aldosteronism present with renal function decline after unilateral adrenalectomies. Our study aimed to assess the evolution o...Yu Ma1,2Xiaofeng Tang1,2Qian Ge1,2Jianzhong Xu1,2Pingjin Gao1,2Jiguang Wang1,2Limin Zhu1,2*
PA Foundation in the News
- Primary Aldosteronism AllianceIn September 2022, the PA Foundation announced the creation of a multistakeholder alliance to drive diagnosis and treatment of primary aldosteronism.
- Dietary Sodium Global Call to ActionThe PA Foundation is one of the co-authors of the World Hypertension League’s call to action published in May 2022 by the Journal of Human Hypertension.
- BMJ Practice Series: Easily Missed?The PA Foundation co-authored the article of the BMJ Practice Series on primary aldosteronism. The open access article was published in April 2022.
- Doctors Overlook a Curable Cause of High BPMIT’s magazine, Undark, featured the PA Foundation in an article of its February 2022 edition dedicated to primary aldosteronism.
Notable Publications of the Year
Primary Aldosteronism in the EROver 40% of patients presenting to the ER of an Australian tertiary health network met the criteria for PA testing. Only 2% were screened.
BPA and Primary Aldosteronism ScreeningImplementation of an EHR best-practice advisory yielded a screening rate of 14%. Most orders were placed by internists (40%) and primary care physicians (28%).
AVS and Asymmetrical Bilateral PAMultifocal, asymmetrical bilateral PA cannot be excluded by robust AVS lateralization. The study’s independent predictors of postoperative residual PA included Black race, AVS lateralization only at baseline, and CT-AVS disagreement.
68Ga-Pentixafor PET/CT and Subtyping of PAIn a study of 123 patients with adrenal micronodules, the sensitivity, specificity, and accuracy of 68Ga-pentixafor PET/CT in subtyping primary aldosteronism were 90.2%, 86.3%, and 89.4%, respectively. The accuracy of AVS examination was lower than that of PET/CT.
Latest News on Hypertension
- Ferrer makes noise about shortcomings of pulmonary hypertension diagnostic, treatment pathways November 20, 2024Ferrer is using Pulmonary Hypertension Awareness Month to sound the alarm about the shortcomings of the current pathways for diagnosing and treating the blood pressure condition. | Ferrer is using Pulmonary Hypertension Awareness Month to sound the alarm about the shortcomings of the current pathways for diagnosing and treating the blood pressure condition.Nick Paul Taylor
- Analysis: Lifetime Cannabis Use Not Associated with Elevated Risk of Hypertension Analysis: Lifetime Cannabis Use Not Associated with Elevated Risk of Hypertension November 20, 2024"Taken together, these studies suggest that regular cannabis use is not associated with elevated blood pressure or hypertension.”NORML
- 'I Have Heart Disease. Here's the First Sign I Noticed.' November 20, 2024How self-advocacy helped one woman find a simple, life-saving solution.Beth Ann Mayer
- Sitting Too Long as a Child? It Could Lead to a Lifelong Blood Pressure Problem November 20, 2024Excessive sedentary time during growth increases systolic blood pressure, while three hours of daily light physical activity can mitigate this risk, as shown by a groundbreaking study spanning childhood to young adulthood. A new study reveals that spending more than six hours a day in sedentary aBy University of Eastern Finland
- The Role of Telemedicine in Improving Hypertension Management Outcomes: A Systematic Review November 20, 2024Telehealth has been proven to be effective in a variety of healthcare settings and has enhanced patient utilization of healthcare services. Little is known about the use of telehealth in the tre...cureusinc
- Preventing troublesome variability in clinical blood pressure measurement November 20, 2024Journal of Human Hypertension - Preventing troublesome variability in clinical blood pressure measurementAuthor notesChengyu LiuJian LiuJianqing LiAlan Murray
